Trials / Completed
CompletedNCT00922961
Research for Predictive Biologic Parameters of Cutaneous Hypersensitivity After Brachytherapy in Breast Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Centre Oscar Lambret · Academic / Other
- Sex
- Female
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
25 patients, treated by brachytherapy in a phase II study "Mammosite" (from 2003 to 2005), will be asked to attend a clinical exam in order to evaluate the late cutaneous toxicity due to brachytherapy. During this consultation, a blood sample will be taken for analysis ( rate of CD8 T-Lymphocyte Apoptosis)
Detailed description
This is an interventional study for the french law
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Blood sample | Blood sample taken for the analysis of the rate of CD8 T-Lymphocyte Apoptosis |
| PROCEDURE | Clinical exam | Assessment of the esthetic score, and the late cutaneous side effect by 2 physicians |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2009-06-17
- Last updated
- 2012-07-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00922961. Inclusion in this directory is not an endorsement.